SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-118076
Filing Date
2016-08-10
Accepted
2016-08-10 17:01:46
Documents
41
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v446266_10q.htm 10-Q 196308
2 EXHIBIT 31.1 v446266_ex31-1.htm EX-31.1 11512
3 EXHIBIT 31.2 v446266_ex31-2.htm EX-31.2 11783
4 EXHIBIT 32.1 v446266_ex32-1.htm EX-32.1 4853
5 EXHIBIT 32.2 v446266_ex32-2.htm EX-32.2 5011
  Complete submission text file 0001144204-16-118076.txt   1399998

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20160630.xml EX-101.INS 218320
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20160630.xsd EX-101.SCH 19197
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20160630_cal.xml EX-101.CAL 15958
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20160630_def.xml EX-101.DEF 92793
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20160630_lab.xml EX-101.LAB 124567
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20160630_pre.xml EX-101.PRE 111935
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 161822158
SIC: 2836 Biological Products, (No Diagnostic Substances)